Literature DB >> 34172502

Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.

Serena Bugatti1,2, Ludovico De Stefano3,2, Silvia Balduzzi3, Maria Immacolata Greco3, Terenzj Luvaro3, Irene Cassaniti4,5, Laura Bogliolo3, Iolanda Mazzucchelli2, Bernardo D'Onofrio3,2, Michele di Lernia3,2, Eleonora Mauric3,2, Daniele Lilleri4, Fausto Baldanti4,5, Antonio Manzo3,2, Carlomaurizio Montecucco3,2.   

Abstract

Entities:  

Keywords:  COVID-19; biological therapy; glucocorticoids; methotrexate; vaccination

Year:  2021        PMID： 34172502     DOI： 10.1136/annrheumdis-2021-220862

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  15 in total

1.  Evaluation of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Levels in Coronavirus Disease Breakthrough Infection During Immunosuppressive Therapy in a Patient with Connective Tissue Disease-Related Interstitial Lung Disease.

Authors:  Takuma Tsuzuki Wada; Kazuhiro Yokota; Sakon Sakai; Machika Soma; Hiroshi Kajiyama; Norihito Tarumoto; Shigefumi Maesaki; Takuya Maeda; Makoto Nagata; Toshihide Mimura
Journal:  Mod Rheumatol Case Rep       Date:  2022-06-22

2.  Immunogenicity 6 months post COVID-19 mRNA-vaccination among adolescents with juvenile idiopathic arthritis on treatment with TNF-inhibitors.

Authors:  Dimitra Dimopoulou; Maria N Tsolia; Nikos Spyridis; Despoina N Maritsi
Journal:  Rheumatology (Oxford)       Date:  2022-07-05       Impact factor: 7.046

3.  Effectiveness and safety of allergen immunotherapy in patients with allergic rhinitis complicated by rheumatic autoimmune diseases: a case series study.

Authors:  Kazuki Fujioka; Akiko Kasahara; Takashi Kida; Wataru Fujii; Takahiro Seno; Makoto Wada; Masataka Kohno; Yutaka Kawahito
Journal:  Allergy Asthma Clin Immunol       Date:  2022-07-11       Impact factor: 3.373

Review 4.  A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders.

Authors:  Farnoosh Seirafianpour; Homa Pourriyahi; Milad Gholizadeh Mesgarha; Arash Pour Mohammad; Zoha Shaka; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2022-04-11       Impact factor: 3.858

5.  Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study.

Authors:  Amir Massarweh; Roi Tschernichovsky; Amos Stemmer; Alexandra Benouaich-Amiel; Tali Siegal; Noa Eliakim-Raz; Salomon M Stemmer; Shlomit Yust-Katz
Journal:  J Neurooncol       Date:  2022-01-12       Impact factor: 4.506

6.  Do JAK inhibitors affect immune response to COVID-19 vaccination? Data from the MAJIK-SFR Registry.

Authors:  Raphaèle Seror; Marine Camus; Jean-Hugues Salmon; Christian Roux; Emmanuelle Dernis; André Basch; Vincent Germain; Charles Leske; Steeve Brousseau; Marie-Elise Truchetet; André Ramon; Jacques-Eric Gottenberg; Renaud Felten; Fabienne Coury; Antoine Colombey; Clément Prati; Xavier Mariette; JérÔme Avouac
Journal:  Lancet Rheumatol       Date:  2021-10-06

7.  Serologic Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Patients With Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-analysis.

Authors:  Atsushi Sakuraba; Alexander Luna; Dejan Micic
Journal:  Gastroenterology       Date:  2021-09-29       Impact factor: 22.682

Review 8.  Response to Vaccines in Patients with Immune-Mediated Inflammatory Diseases: A Narrative Review.

Authors:  Beatriz Garcillán; Miguel Salavert; José R Regueiro; Sabela Díaz-Castroverde
Journal:  Vaccines (Basel)       Date:  2022-02-15

9.  Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis.

Authors:  Maurizio Benucci; Arianna Damiani; Francesca Li Gobbi; Barbara Lari; Valentina Grossi; Maria Infantino; Mariangela Manfredi
Journal:  Immunol Res       Date:  2022-05-11       Impact factor: 4.505

Review 10.  Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines in Rheumatic Patients: An Updated Systematic Review and Meta-Analysis.

Authors:  Kuo-Tung Tang; Bo-Chueh Hsu; Der-Yuan Chen
Journal:  Biomedicines       Date:  2022-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.